Efimov Falls to 9% in Fields Medal Race on $159 of Competitor Volume

---

Alexander Efimov's Fields Medal Odds Halved, But What Actually Changed?

No preprint was retracted. No eligibility question surfaced. No mathematician published a critique of Alexander Efimov's contributions to algebraic K-theory or non-commutative geometry. In the 72 hours ending June 23, 2026, the only thing that changed about Efimov's Fields Medal candidacy was the number next to his name on two prediction platforms.

That number fell from 18% to 9%, a 9 percentage point collapse that cut his implied probability in half. On Kalshi, Efimov now trades at 10%. On Polymarket, he sits at 8%. The 2-point cross-platform spread is narrow enough to call reliable, meaning both platforms agree on the direction even if neither can claim deep conviction on the level.

The drop demands an explanation. In a market where the International Congress of Mathematicians is five weeks away and the Fields Medal committee's deliberations are entirely opaque, a 9 percentage point swing should correspond to real information. The problem: there is none. Efimov's collapse appears to be a mechanical casualty of capital flowing into two competing names in a market too thin to absorb the rebalancing gracefully.

---

Why Alexander Efimov Was a Serious Fields Medal Contender to Begin With

The 18% price Efimov held before the drop was not a speculative flier. It was anchored to a credential set that the mathematical community recognizes as Fields-adjacent. In 2020, the European Mathematical Society awarded Efimov its EMS Prize, given every four years to ten outstanding European mathematicians under 35. Past EMS Prize recipients include Artur Avila, who won the Fields Medal in 2014, and Peter Scholze, who won it in 2018.

Efimov's research sits at the intersection of derived algebraic geometry and homological algebra. His work on algebraic K-theory of large categories and his contributions to non-commutative geometry have earned recognition well beyond the EMS Prize circuit. He remains a research fellow at HSE University's International Laboratory for Mirror Symmetry and Automorphic Forms, a position that places him at the center of an active research program.

Age eligibility is not in question. The Fields Medal requires recipients to be under 40 on January 1 of the award year. Efimov qualifies. His mathematical output has not slowed. No controversy has attached to his name. By every observable metric, the candidate who deserved 18% a week ago still deserves something close to it today.

---

The $159 Logunov Surge and Sahasrabudhe Repricing That Crowded Out Efimov

The proximate cause of Efimov's decline is not subtraction from his case but addition to others. Two competitors absorbed capital in rapid succession, and the probability pool compressed everyone else.

First, Aleksandr Logunov's contract surged 16 percentage points earlier this cycle, rising from 14% to 30%. As Prediction Hunt reported in April, the entire repricing was driven by approximately $159 in total Polymarket volume. That figure is the concrete proof point: the mechanism that compressed Efimov's probability was built on less capital than a restaurant bill. In a deep market, $159 would not move a price by a single point. In this one, it manufactured a 16 percentage point swing that cascaded through the entire candidate field.

Second, Julian Sahasrabudhe's odds climbed to 40% after his Adams Prize and ICM 2026 speaking invitation repriced his candidacy, as Prediction Hunt covered in March. That move was more fundamentally justified, backed by real credentials. But the effect on the broader market was the same: probability mass migrated upward toward two names, and candidates in the 10-20% range, including Efimov, absorbed the squeeze.

The Fields Medal awards up to four recipients per cycle. In theory, the market is not zero-sum: Efimov can win alongside Hong Wang (83%), Jacob Tsimerman (63%), and Jack Thorne (51%). In practice, automated market maker curves on low-volume contracts behave as if it is zero-sum, because each dollar spent on one name shifts the AMM pricing for all others. When total participation is measured in hundreds of dollars rather than hundreds of thousands, the contagion is immediate and disproportionate.

---

The Strongest Case Against Efimov: What Would Have to Be True for 9% to Be Right

A fair analysis requires acknowledging the bearish case honestly. Here it is: 9% might be correct if the 2026 field is historically deep, which it appears to be.

Hong Wang's proof resolving the Kakeya conjecture across all dimensions is the kind of singular achievement that Fields Medal committees reward above all else. Tsimerman and Thorne carry probability above 50%, reflecting sustained, multi-year bodies of work that have drawn broad recognition. Yu Deng sits at 37%, John Pardon at 30%, Sahasrabudhe at 31%, and Logunov at 20%. Efimov, at 9%, ranks below all of them.

The EMS Prize is a qualifier, not a guarantee. Many past recipients never won the Fields Medal. The committee typically selects four laureates from a global pool, and the 2026 cycle features an unusually large cluster of candidates with strong, distinct claims. If you believe that Wang, Tsimerman, Thorne, and one of Deng/Sahasrabudhe/Pardon are the likely four, then there is simply no slot left for Efimov. Under that framework, 9% is generous.

There is also a visibility argument. Efimov's work in non-commutative geometry, while deep, does not carry the public-facing narrative momentum that a conjecture resolution provides. The Fields Medal committee has historically rewarded both types of contribution, but in a crowded year, the tiebreaker often goes to the candidate whose result is easiest to explain to the broader mathematical community.

---

What 9% Means With Five Weeks to Resolution

At 9%, the market assigns Efimov roughly a 1-in-11 chance of hearing his name called in Philadelphia on July 30. That price implies near-certainty that he will not win. For a 2020 EMS Prize recipient with no disqualifying developments, that level of certainty should require affirmative evidence, not the residue of a $159 bet on someone else.

The honest read: Efimov's 9% is likely too low if you believe thin-market mechanics drove the drop, and roughly fair if you believe the 2026 field is so deep that four other names will fill the committee's slate before Efimov's is considered. Both positions are defensible. Neither has been tested by new information.

The resolution window closes in five weeks. Until then, the most important variable for Efimov's contract is not mathematics. It is whether anyone deposits enough capital into his contract to correct what looks, on the available evidence, like a liquidity-driven misprint.